← back to search

Margaret Doyle

University of Vermont · US
Area of research
Hematology · Genetics
Research interest
Research focused on Refractory (planetary science) and Immunology, with related work in Multiple myeloma, Coronavirus disease 2019 (COVID-19), Neutropenia. Notable publications include 'Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation', 'Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study', and 'Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma'.
h-index
—
citations
212
works
4
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study
Blood Cancer Journal 2024cited by 6position: middledoi
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
Blood Advances 2023cited by 73position: middledoi
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC‐1 study
Cancer 2023cited by 72position: middledoi
Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myeloma
Cancer 2023cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ajay K. Nooka · Emory University4 papers (2023–2024)María‐Victoria Mateos · Spanish Society of Hematology and Hemotherapy4 papers (2023–2024)Niels W.C.J. van de Donk · National Cancer Center4 papers (2023–2024)— · 3 papers (2023–2024)Cesar Rodriguez · Mount Sinai Hospital3 papers (2023–2023)Rachel Kobos · Janssen (United States)3 papers (2023–2023)Raluca Verona · Johnson & Johnson (United States)3 papers (2023–2023)Arnob Banerjee · Janssen (United States)3 papers (2023–2023)Thomas G. Martin · City College of San Francisco3 papers (2023–2023)Clarissa Uhlar · Janssen (United States)3 papers (2023–2024)Keqin Qi · Johnson & Johnson (United States)2 papers (2023–2024)— · 1 papers (2023–2023)Hans L. Zaaijer · Sanquin1 papers (2023–2023)Ming Qi · University of Cape Town1 papers (2023–2023)— · 1 papers (2023–2023)Sheri Skerget · Arizona State University1 papers (2023–2023)— · 1 papers (2023–2023)Luciano J. Costa · Baylor University1 papers (2024–2024)Saad Z. Usmani · Weill Cornell Medicine1 papers (2024–2024)Bronno van der Holt · Hovon1 papers (2023–2023)